Arnd Christ has served as Chief Financial Officer of Immatics since 2020 and brings nearly two decades of experience serving as CFO of both private and public biotechnology companies.
Before joining Immatics, he was CFO of several companies including InflaRx N.V., Proteros Biostructure GmbH, MediGene AG, NovImmune SA, Probiodrug AG and EleGene AG.
Over the cause of his career, Arnd completed a broad range of corporate transactions including an IPO, capital raises and licensing deals. Prior to serving as a CFO, he held the position of Financial Director in various corporations related to the former Hoechst Group in Germany and the UK.
Arnd holds a diploma in business economics from the University of Würzburg, Germany.